A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

Dominique Bremond-Gignac1 Ophthalmology Department, Centre St Victor, University Hospital of Amiens, Picardie Jules Verne University, Amiens, France;2 CNRS FR3636, Paris V University, FranceCorrespondence[email protected]

Riadh Messaoud3 Ophthalmology Department, Tahar Sfar University Hospital, Mahdia, Tunisia

Sihem Lazreg4 Dar El Beida, Blida, Algeria

Claude Speeg-Schatz5 Ophthalmology Department, University Hospital of Strasbourg, Strasbourg, France

Didier Renault6 Laboratoires THÉA, Clermont-Ferrand, France

Frédéric Chiambaretta7 Ophthalmology Department, University Hospital of Clermont-Ferrand, Gabriel Montpied Hospital, Clermont-Ferrand, France;8 EA 7281 R2D2, Auvergne University, Clermont-Ferrand, France

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A 3-day regimen with azithromycin 1.5% eyedrops for the treatment of purulent bacterial conjunctivitis in children: efficacy on clinical signs and impact on the burden of illness

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date